Members |
targetComponentId |
Auditory/vestibular test normal (& [hearing] or [audiogram]) |
Hearing test normal |
Auditory/vestibular test normal (& [hearing] or [audiogram]) |
Audiogram normal |
Auditory/vestibular test normal (& [hearing] or [audiogram]) |
Auditory/vestibular test normal (finding) |
Auditory/vestibular test normal (& [hearing] or [audiogram]) |
Audiogram normal |
Auditory/vestibular test normal (& [hearing] or [audiogram]) |
Hearing test normal |
Auditory/vestibular test normal (& [hearing] or [audiogram]) |
Auditory/vestibular test normal (finding) |
Augmentation - action |
Surgical augmentation - action |
Aurantimonas species |
Genus Aurantimonas (organism) |
Auscultation - action |
Auscultation - action |
Auscultation - action |
Auscultation |
Australian echidna |
Family Tachyglossidae (organism) |
Australian echidna |
Tachyglossus aculeatus (organism) |
Australian pine pollen allergen |
Australian pine pollen |
Australian thick-knee |
Burhinus giganteus (organism) |
Australian thick-knee |
Burhinus grallarius (organism) |
Autoaugmentation of bladder |
Autoaugmentation of urinary bladder |
Autoaugmentation of bladder |
Clam cystoplasty |
Autogenous skin free graft |
Split thickness graft of skin to skin (procedure) |
Autogenous skin free graft |
Full thickness autograft of skin (substance) |
Autogenous vaccine - autogenous bacterin |
Vaccine product |
Autoimmune haemolytic anaemia |
Hemolytic disease of fetus OR newborn due to isoimmunization (disorder) |
Autoimmune haemolytic anaemia |
Autoimmune hemolytic anemia (disorder) |
Autoimmune hemolytic anemia |
Hemolytic disease of fetus OR newborn due to isoimmunization (disorder) |
Autoimmune hemolytic anemia |
Autoimmune hemolytic anemia (disorder) |
Autoimmune progesterone dermatitis/urticaria |
Autoimmune progesterone dermatitis |
Autoimmune progesterone dermatitis/urticaria |
Menstrual urticaria |
Autologous 12million chondrocyte cells injection solution vial for implantation |
Product containing precisely autologous cultured chondrocyte 30 million unit/1 milliliter conventional release intraarticular implant (clinical drug) |
Automatic cranial perforator, reusable |
Automatic-releasing cranial perforator |
Automatic cranial perforator, single-use |
Automatic-releasing cranial perforator |
Automatic pneumatic pulmonary resuscitator, reusable |
Automatic pulmonary resuscitator (physical object) |
Automatic pneumatic pulmonary resuscitator, single-use |
Automatic pulmonary resuscitator (physical object) |
Autonomic nervous system poisoning NOS |
Poisoning by drug AND/OR medicinal substance |
Autopen 1.5mL one unit device |
Injection device |
Autopen 1.5mL two unit device |
Injection device |
Autopen 3mL two unit device |
Injection device |
Autopen device |
Injection device |
Autopsied body |
Autopsied body (finding) |
Autosomal dominant analbuminemia |
Congenital analbuminemia (disorder) |
Autosomal dominant epidermolysis bullosa simplex |
Epidermolysis bullosa simplex, Ogna type (disorder) |
Autosomal dominant epidermolysis bullosa simplex |
Autosomal dominant epidermolysis bullosa simplex (disorder) |
Autosomal dominant isolated somatotropin deficiency |
Ateliotic dwarfism without insulinopenia |
Autosomal dominant isolated somatotropin deficiency |
Autosomal dominant isolated somatotropin deficiency |
Autosomal recessive muscular dystrophy with gene located at 15q |
Autosomal recessive limb girdle muscular dystrophy type 2A (disorder) |
Hereditary sensory and autonomic neuropathy, type II |
Hereditary sensory and autonomic neuropathy type II (disorder) |
Hereditary sensory and autonomic neuropathy, type II |
Charcot-Marie-Tooth disease, type II (disorder) |
Hereditary sensory and autonomic neuropathy, type II |
Hereditary insensitivity to pain with anhidrosis |
Autosomal recessive spondyloepimetaphyseal dysplasia |
Spondyloepimetaphyseal dysplasia Irapa type (disorder) |
Autotransplantation of pancreatic tissue |
Autotransplantation of pancreatic tissue |
Autotransplantation of pancreatic tissue |
Reimplantation of pancreatic tissue |
Avascular necrosis of femoral condyle (& [medial]) |
Avascular necrosis of medial femoral condyle (disorder) |
Avian adeno-associated virus |
Goose parvovirus (organism) |
Avian adeno-associated virus |
Muscovy duck parvovirus (organism) |
Avian adenovirus 2 antibody |
Turkey adenovirus 3 antibody (substance) |
Avian adenovirus 2 antibody assay |
Measurement of Turkey adenovirus 3 antibody (procedure) |
Avian herpesvirus |
Gallid herpesvirus 1 (organism) |
Avian herpesvirus |
Gallid herpesvirus 2 (organism) |
Avian herpesvirus |
Anatid herpesvirus 1 (organism) |
Avian herpesvirus |
Gallid herpesvirus 3 (organism) |
Avian infectious bronchitis virus Ark-99 |
Antibody to Avian infectious bronchitis virus Ark-99 (substance) |
Avian influenza |
Influenza caused by Influenza A virus (disorder) |
Avian influenza virus, highly pathogenic |
Influenza A virus (organism) |
Avian influenza virus, low pathogenic |
Influenza A virus (organism) |
Avian parvovirus |
Muscovy duck parvovirus (organism) |
Avian parvovirus |
Goose parvovirus (organism) |
Avian parvovirus |
Chicken parvovirus (organism) |
Avian reticuloendotheliosis virus |
Reticuloendotheliosis virus (strain T,A) (organism) |
Avian reticuloendotheliosis virus |
Reticuloendotheliosis virus (organism) |
Avian sarcoma virus |
Rous sarcoma virus (organism) |
Avian sarcoma virus |
Avian sarcoma virus (organism) |
Avian type C oncovirus group |
Reticuloendotheliosis virus (organism) |
Avian type C oncovirus group |
Genus Alpharetrovirus (organism) |
Avibactam and ceftazidime |
Product containing avibactam and ceftazidime (medicinal product) |
Avioserpens species |
Avioserpens (organism) |
Avocet |
Genus Recurvirostra (organism) |
Avulsion leg varicose vein (& Babcock) |
Avulsion of varicose vein of leg |
Avulsion of eye |
Traumatic enucleation of eye |
Axenfeld's anomaly |
Posterior embryotoxon (disorder) |
Axenfeld's anomaly |
Axenfeld anomaly |
Axilla |
Entire axillary region |
Axilla |
Entire axillary fossa (body structure) |
Axilla |
Entire axillary fossa (body structure) |
Axilla |
Structure of axillary fossa (body structure) |
Axilla |
Entire axillary region |
Axilla |
Structure of axillary fossa (body structure) |
Axilla |
Axillary region structure |
Axilla |
Axillary region structure |
Axilla structure |
Structure of axillary fossa (body structure) |
Axilla structure |
Axillary region structure |
Axillary artery and its branches |
Structure of axillary artery |
Axillary artery and its branches |
Entire axillary artery |
Axillary line of trunk |
Posterior axillary line structure |
Axillary line of trunk |
Anterior axillary line structure |
Axillary vein and its tributaries |
Structure of axillary vein |
Axillary vein and its tributaries |
Entire axillary vein |
Axillary-femoral arterial bypass |
Axillary-femoral arterial bypass (procedure) |
Axillary-femoral arterial bypass |
Superficial axillofemoral vascular bypass (procedure) |
Axitinib 1mg tablet |
Product containing precisely axitinib 1 milligram/1 each conventional release oral tablet (clinical drug) |
Axitinib 5mg tablet |
Axitinib 5 mg oral tablet |
Ayala's disease |
Langerhans cell histiocytosis |
Azatadine maleate 500micrograms/5mL syrup |
Azatadine maleate 100 microgram/mL oral solution |
Azathioprine [immunosuppressant] |
Product containing azathioprine (medicinal product) |